金石亚药：董事郑志勇和股东姜二晨分别减持0.06%和0.02%

Group 1 - The company announced that board member Zheng Zhiyong and shareholder Jiang Erchen have completed their share reduction plans [1] - Zheng Zhiyong plans to reduce 240,000 shares at an average price of 10.9 yuan per share, accounting for 0.06% of the total share capital, between December 26, 2025, and January 22, 2026 [1] - Jiang Erchen intends to reduce 70,000 shares at an average price of 13.18 yuan per share, representing 0.02% of the total share capital, on November 26, 2025 [1] Group 2 - After the share reductions, Zheng Zhiyong will hold 3.4653 million shares, which is 0.86% of the total share capital [1] - Jiang Erchen will hold 157,000 shares, accounting for 0.04% of the total share capital after the reduction [1]